Clinical trials
Phase 2 Hodgkin Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Completed | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 3 |
| Beijing Children's Hospital | 1 |
| CStone Pharmaceuticals | 1 |
| Fudan University | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Peking University | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 13 |
| Recurrence | 3 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.